AHP buyout of Genetics Institute marks departure from Roche/Genentech model for biotech agreement.
AHP BUYOUT OF GENETICS INSTITUTE IS DEPARTURE FROM ROCHE/GENENTECH model of brandname/biotech partnerships followed by American Home Products when it acquired a majority stake in Genetics Institute in 1991. That agreement was patterned on Roche's partial acquisition of Genentech. Both deals gave the parent company the option to buy out the rest of the biotech firm at set prices over five years.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth